Sundew Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 19 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 10.69%
- Profit Growth 23.07%
- Ebitda 23.39%
- Net Worth -229.95%
- Total Assets -2.03%
About Sundew Life Sciences
Sundew Life Sciences Private Limited (SLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 July 2005 and has a history of 19 years and seven months. Its registered office is in Erode, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Gobinath Ganesan and Kailash Rajendran serve as directors at the Company.
Company Details
-
Location
Erode, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U02423TZ2005PTC011983
-
Company No.
011983
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Jul 2005
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Sundew Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gobinath Ganesan
|
Director | 13-Mar-2007 | Current |
|
Kailash Rajendran
|
Director | 16-Oct-2012 | Current |
Financial Performance of Sundew Life Sciences.
Sundew Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.69% increase. The company also saw a substantial improvement in profitability, with a 23.07% increase in profit. The company's net worth observed a substantial decline by a decrease of 229.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sundew Life Sciences?
In 2023, Sundew Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ennvee Solutions Private LimitedKailash Rajendran is a mutual person
-
Kaladi Consulting Services Private LimitedKailash Rajendran is a mutual person
-
Opinio Global Services Private LimitedGobinath Ganesan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sundew Life Sciences?
Unlock and access historical data on people associated with Sundew Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sundew Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sundew Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
